“Comparison of Clinical Effectiveness of Folfirinox Versus Gemcitabine on Quality of Life in Patients With Pancreatic Cancer Stage IV”. Asian Journal of Pharmaceutics (AJP), vol. 11, no. 03, Oct. 2017, https://doi.org/10.22377/ajp.v11i03.1468.